1 312-422-1111
ibioadmin@ibio.org

Blog

IL ­ HB1441 IMPORTED PRESCRIPTION DRUGS – OPPOSE

Primary Sponsor: Representative Anna Moeller (D)

Track Bill

Summary

Creates the Wholesale Importation of Prescription Drugs Act. Requires the Department of Public Health to design an importation program where the State is the licensed wholesaler of imported drugs from licensed, regulated Canadian suppliers. Requires the program to address specified issues, including billing issues, cost savings issues, and safety and regulatory issues. Contains auditing and reporting requirements. Provides that the Department shall enlist the assistance of the Attorney General to identify the potential for anti­competitive behavior in industries that would be affected by an importation program. Requires the Department to submit a formal request to the Secretary of the United States Department of Health and Human Services for certification of the importation program. Requires the Department to have the program operational within 6 months after receiving the certification. Contains provisions concerning implementation requirements.

Read more

IL ­ HB349 DRUG AND SHARPS WASTE PROGRAM – OPPOSE

Creates the Drug and Sharps Waste Stewardship Act. Directs the Environmental Protection

Agency to administer a drug and sharps waste stewardship program.
Last Action: Referred to Rules Committee (January 14, 2019)
Primary Sponsor: Representative Kelly M. Cassidy (D)

Track Bill

Read more

IL ­ HB156 BIOLOGICAL PRODUCTS­ DRUG PRICE – OPPOSE

Creates the Prescription Drug Pricing Transparency Act. Amends the Pharmacy Practice Act. Provides that when a pharmacist receives a prescription for a biological product, the pharmacist shall select the lowest priced interchangeable biological product (rather than allowing a pharmacist to substitute an interchangeable biological product only if certain requirements are met).

Last Action: Assigned to Prescription Drug Affordability & Accessibility Committee (January 29, 2019)Primary Sponsor: Representative Mary E. Flowers (D)

Track Bill

Read more

IL ­ HB53 DRUG MANUFACTURER­ DISCLOSURES – OPPOSE

Requires manufacturers of brand name or generic prescription drugs to notify State purchasers, health insurers, health care service plan providers, pharmacy benefit managers, and the General Assembly of specified increases in drug prices at least 60 days before such increase and the cost of specified new prescription drugs within 3 days after approval by the U.S. Food and Drug Administration

Last Action: Assigned to Prescription Drug Affordability & Accessibility Committee (January 29, 2019)Primary Sponsor: Representative Mary E. Flowers (D)

Track Bill

Read more

iBIO’s StellarGirls After School Program Expands into North Chicago

We are excited to announce that the StellarGirls program will expand into North Chicago. The Neal Math and Science Academy will provide the program to all of their 98 girls in 6th grade.

Read more

BioVie Receives $3.2 Million Equity Investment

On July 3, 2018, BioVie Inc. (OTCQB: BIVI), an iBIO PROPEL company developing innovative drug therapies for liver disease, executed an agreement with Acuitas Group Holdings, LLC (“Acuitas”) and certain other investors to purchase $3.2 million of the Company’s Series A Preferred Stock

Read more

The iBIO Institute Honors Life Sciences Educators, Innovators and Entrepreneurs at the 12th Annual iCON Awards

This evening, the iBIO Institute hosted the twelfth annual iCON awards last night at The Chicago Botanic Garden.

Read more

iBIO Institute Announces Winner of “Illinois BioGENEius Challenge” Student Competition

Winner moves on to compete in the International Competition this summer for a chance to win a cash prize

CHICAGO – April 11, 2018 – Today, Haley Martens from Oak Park River Forest High School took first place at the Illinois BioGENEius Challenge, an annual student science and research competition hosted by the iBIO Institute EDUCATE Center and sponsored by Horizon Pharma.

Read more

John Conrad Named President & CEO of the Illinois Biotechnology Innovation Organization (iBIO) and the iBIO Institute

The Illinois Biotechnology Innovation Organization (iBIO) today announced that John Conrad has been named President & CEO of iBIO and the iBIO Institute.

Read more

iBIO Institute Announces 2018 Illinois BioGENEius Challenge

Is there a BioGENEius in Your Classroom?

iBIO Institute EDUCATE Center, an Illinois non-profit focused on science, technology, engineering and mathematics (STEM) education, wants to know!

Read more